Free Trial

Voyageur Pharmaceuticals (CVE:VM) Trading 12.7% Higher - Here's Why

Voyageur Pharmaceuticals logo with Medical background

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM - Get Free Report) traded up 12.7% during trading on Friday . The stock traded as high as C$0.31 and last traded at C$0.31. 309,782 shares changed hands during trading, an increase of 63% from the average session volume of 189,521 shares. The stock had previously closed at C$0.28.

Voyageur Pharmaceuticals Stock Up 23.6%

The company has a quick ratio of 0.84, a current ratio of 0.10 and a debt-to-equity ratio of 4.23. The company has a 50 day simple moving average of C$0.19 and a two-hundred day simple moving average of C$0.16. The company has a market capitalization of C$51.52 million, a P/E ratio of -31.80 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Voyageur Pharmaceuticals Right Now?

Before you consider Voyageur Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Voyageur Pharmaceuticals wasn't on the list.

While Voyageur Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines